Microba Life Sciences (ASX:MAP) Ending Cash Position : A$27.85 Mil (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Microba Life Sciences Ending Cash Position?

Microba Life Sciences's Ending Cash Position for the quarter that ended in Dec. 2023 was A$27.85 Mil.

Microba Life Sciences's quarterly Ending Cash Position declined from Dec. 2022 (A$41.95 Mil) to Jun. 2023 (A$32.04 Mil) and declined from Jun. 2023 (A$32.04 Mil) to Dec. 2023 (A$27.85 Mil).

Microba Life Sciences's annual Ending Cash Position increased from . 20 (A$0.00 Mil) to Jun. 2022 (A$30.58 Mil) and increased from Jun. 2022 (A$30.58 Mil) to Jun. 2023 (A$32.04 Mil).

Microba Life Sciences Ending Cash Position Historical Data

The historical data trend for Microba Life Sciences's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microba Life Sciences Ending Cash Position Chart

Microba Life Sciences Annual Data

Trend

Jun22

Jun23

Ending Cash Position

30.58

32.04

Microba Life Sciences Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
Ending Cash Position	-	-	41.95	32.04	27.85

Microba Life Sciences Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Microba Life Sciences's Ending Cash Position for the fiscal year that ended in Jun. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	30.582	+	1.462
	=	32.04

Microba Life Sciences's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	32.045	+	-4.199
	=	27.85

Microba Life Sciences Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Microba Life Sciences's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Microba Life Sciences (ASX:MAP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Microba Life Sciences Ltd (ASX:MAP) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

324 Queen Street, Level 10, Brisbane, QLD, AUS, 4000

Website

https://www.microba.com

Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome which includes delivering gut microbiome testing services globally to consumers, clinicians, and researchers. The company's segment includes Testing Services, and Research and Development.

Microba Life Sciences (ASX:MAP) Headlines

No Headlines